Promoting Cognitive Health in Schizophrenia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorDouglas Mental Health University Institute
About this trial
The goal of this clinical trial is to effectively implement virtually-delivered interventions in mental health institutions nationwide to improve the cognitive health of individuals living with schizophrenia. The main objectives are:
* To determine the clinical effectiveness of two virtual cognitive health interventions (i.e., Action-Based Cognitive Remediation or MetaCognitive Training). * To evaluate our implementation strategy involving the virtual delivery of cognitive health interventions combined with a digital learning platform to train mental health practitioners.
Participants will be assessed for the severity of symptoms, cognitive performance, and overall functioning before and after receiving the intervention. Qualitative interviews will also be conducted with participants and therapists to evaluate the implementation strategies.
Eligibility criteria
Qualifiers
Diagnosis of affective or non-affective psychosis or related disorder;
Follow-up and treatment by a clinician at one of the services mentioned above;
Participants symptomatically stable and capable of using the online platforms and participating in intervention groups, as judged by their primary clinicians (i.e., psychiatrist, case manager);
Participants must have access to a private space (i.e., a room where the participant can be alone) to ensure confidentiality for the group;
Disqualifiers
Intellectual disability;
Hospitalization at the time of recruitment;
Inability to speak or read English or French;
High suicide risk as per evaluation.
Trial design
Treatments tested in this trial
- Cognitive remediation
- MetaCognitive Training
Treatment groups
390 Participants
are divided into 2 treatment groupsSponsors and collaborators
Douglas Mental Health University Institute
Lead sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator
McGill University
Collaborator
Source ClinicalTrials.gov